Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019
- PMID: 34374752
- DOI: 10.1093/infdis/jiab400
Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019
Abstract
Background: Lymphopenia is a key feature for adult patients with coronavirus disease 2019 (COVID-19), although it is rarely observed in children. The underlying mechanism remains unclear.
Methods: Immunohistochemical and flow cytometric analyses were used to compare the apoptotic rate of T cells from COVID-19 adults and children and apoptotic responses of adult and child T cells to COVID-19 pooled plasma. Biological properties of caspases and reactive oxygen species were assessed in T cells treated by COVID-19 pooled plasma.
Results: Mitochondria apoptosis of peripheral T cells were identified in COVID-19 adult patient samples but not in the children. Furthermore, increased tumor necrosis factor-α and interleukin-6 in COVID-19 plasma induced mitochondria apoptosis and caused deoxyribonucleic acid damage by elevating reactive oxygen species levels of the adult T cells. However, the child T cells showed tolerance to mitochondrial apoptosis due to mitochondria autophagy. Activation of autophagy could decrease apoptotic sensitivity of the adult T cells to plasma from COVID-19 patients.
Conclusions: Our results indicated that the mitochondrial apoptosis pathway was activated in T cells of COVID-19 adult patients specifically, which may shed light on the pathophysiological difference between adults and children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ).
Keywords: COVID-19; adult; children; lymphopenia; mitochondria apoptosis.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Publication types
MeSH terms
Substances
Grants and funding
- 31470877/National Natural Science Foundation of China
- 2017ZX10302301-002/National Science and Technology Key Projects for Major Infectious Diseases
- 2017004/Support Scheme of Guangzhou for Leading Talents in Innovation and Entrepreneurship
- 2020A111128022, 2020B111112003/Guangdong Scientific and Technological Research Project for Prevention and Treatment of COVID-19
- 202020012612200001/Guangdong Scientific and Technological Research Special Fund for COVID-19
- ZH22036302200029PWC/Zhuhai Scientific and Technological Research Project for COVID-19 Containment
- ZH22046301200018PWC/Zhuhai Industrial Technological Research and Development Project for Prevention and Treatment of COVID-19
- 201704020226/Science and Technology Planning Project of Guangzhou
- FSSYKF-2020003, FSSYKF-2020017/Development Project of Foshan Fourth People's Hospital
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
